The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation-Reference-Cited by-同舟云学术

The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation

Published:1999-06 Issue:5 Volume:32 Page:961-976
ISSN:0950-382X
Container-title:Molecular Microbiology
language:en
Short-container-title:Mol Microbiol

Author:

Pettersson Jonas,Holmstrom Anna,Hill Jim,Leary Sophie,Frithz-Lindsten Elisabet,von Euler-Matell Anne,Carlsson Eva,Titball Richard,Forsberg Ake,Wolf-Watz Hans

Publisher

Wiley

Subject

Molecular Biology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2958.1999.01408.x/fullpdf

Reference69 articles.

1. YscU, a Yersinia enterocolitica inner membrane protein involved in Yop secretion

2. VirG, a Yersinia enterocolitica lipoprotein involved in Ca2+ dependency, is related to exsB of Pseudomonas aeruginosa

3. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

4. 4G.E. Benner, S. Chanteau, M. Rasolomaharo, and A.M. Friedlander (1998 ) The immune response toYersiniaouter proteins (Yops) and otherYersiniaantigens in human plague cases. Abstract no. B-159 page 82, presented at the American Society for Microbiology 98th General Meeting.

5. Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yersinia enterocolitica;Molecular Medical Microbiology;2024

2. Live attenuated vaccines and layered defense strategies to combat infections caused by nonencapsulated Yersinia pestis;Frontiers in Bacteriology;2023-09-22

3. Macrophage innate immune responses delineate between defective translocon assemblies produced by Yersinia pseudotuberculosis YopD mutants;Virulence;2023-08-24

4. Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague;Antibodies;2023-05-08

5. Plague Prevention and Therapy: Perspectives on Current and Future Strategies;Biomedicines;2021-10-09